Joseph Graskemper

Founder & Principal at Pathways Pharma Consulting, LLC

Speaker

Joe Graskemper, Founder & Principal of Pathways Pharma Consulting, is a CMC leader with over 15 years of experience across both pharmaceutical and biotechnology industries. Joe has held various roles in development, program management, and manufacturing supporting assets across multiple modalities from preclinical through commercial stages. Prior to launching Pathways Pharma Consulting, he has worked at both small and large companies, including Purdue Pharma, Alkermes, Biogen, Translate Bio (Sanofi), Solid Biosciences, and Intergalactic Therapeutics leading to successful regulatory filings for multiple products; most notably, Joe has helped commercialize LYBALVI®, buprenorphine, and naloxone.

Joe is a member of the Outsourced Pharma Advisory Board. He holds a M.S. in Organic Chemistry from the University of Nebraska-Lincoln, dual degrees from Roger Williams University in Chemistry (B.A.) and Marine Biology (B.S.), and a mini-MBA from Rutgers Business School.